INTRODUCTION
============

Native arteriovenous fistula (AVF) is recommended as a first AV access in end stage renal disease paitents who need hemodialysis \[[@b1-vsi-31-20]\]. Many reports have shown variable postoperative results \[[@b2-vsi-31-20],[@b3-vsi-31-20]\], and early failure rates are considerable in some reports \[[@b4-vsi-31-20],[@b5-vsi-31-20]\]. Postoperative palpable thrill suggests successful native AVF creation \[[@b6-vsi-31-20]\] and practitioners wait several weeks for maturation to occur. However in some cases, postoperative thrill may be very weak or absent, with or without pulsation. In this case, the operator chooses one of following methods. First, reopen the wound and explore the created AVF. Second, wait several days with no further manipulation. Third, create a new AVF proximally or at the other arm. Fourth, perform angiography and immediate postoperative balloon angioplasty (IPBA); the latter is a less commonly used method that we would like to mention in this paper.

We reviewed cases of IPBA which was performed when postoperative AVF flow was threatened (newly-created AVF with no thrill) and effectiveness, safety and usefulness of IPBA were evaluated.

MATERIALS AND METHODS
=====================

From January 1, 2012 to March 31, 2014, 1,270 patients received autogenous AVF creations in a single vascular clinic. Among these patients, 24 patients (24/1,270 patients, 1.9%) were selected retrospectively who underwent IPBA after AVF creation and had a follow-up period of more than 3 months.

Arm veins and arteries were examined by physical examination and duplex scan preoperatively. In 24 patients, postoperative AVF flow was poor even with preoperative tests. If newly-created AVF flow did not get better by physical examination after 30 minutes of observation, we checked the operation site with direct angiography and IPBA was done. IPBA was initiated with puncture of the distal artery from the anastomosis. In every case, a 5-French sheath was inserted. We checked for flow-limiting lesions (significant stenosis over 60% by angiography) and the lesions were ballooned. Flow restoration was confirmed by palpation with or without duplex scan. After IPBA, we checked the AV access maturation with regular surveillance; 2, 4, 8 and every 12 weeks. If needed, secondary balloon angioplasty was done to enhance access maturation.

Technical success was defined as restoration of AVF flow; meaning the presence of good thrill with relieved stenosis after ballooning during angiography. Clinical success was defined as successful maturation of the flow-limiting, newly-created native AVF to become functional for use during hemodialysis after several weeks of maturation time. Maturation time refers to the required time from native AVF formation to first use as access for hemodialysis. Primary patency rate and fistula survival outcome were analyzed during the follow-up period. IBM SPSS Statistics 19.0 (IBM Co., Armonk, NY, USA) was used for statistical analysis.

RESULTS
=======

In 24 cases of IPBA, most of the initial operations were wrist or forearm radiocephalic AVFs ([Table 1](#t1-vsi-31-20){ref-type="table"}). In preoperative duplex scan, vein diameters were less than 2.5 mm in 62.5% and artery diameters were less than 2 mm in 62.5% of the cases ([Table 2](#t2-vsi-31-20){ref-type="table"}). Postoperative angiography was performed via wrist radial artery puncture, except in 1 case of elbow brachial artery puncture. Most of the flow-limiting lesions were vein stenoses and plain balloon catheters with 4 mm diameter were used in 66.7% (16/24) of the patients.

Threatened AVF flow was restored successfully in 23 patients, except in 1 case of guide-wiring passage failure (23/24 patients, 95.8% of technical success rate). In the single failed case, proximal re-anastomosis was done. In 23 patients with successful IPBA, all AVFs matured to functional AVFs with mean±standard deviation, 4.5±1.5 weeks of maturation time. In seven patients (7/23 patients, 30.4%), secondary balloon angioplasty was performed to enhance maturation ([Table 3](#t3-vsi-31-20){ref-type="table"}).

The overall primary patency after IPBA was 69.6% at 1 and 6 months and 59.0% at 12 months ([Fig. 1](#f1-vsi-31-20){ref-type="fig"}). There was 1 case of operation site hematoma after immediate postoperative PTA, and the hematoma was evacuated with preserved AVF flow.

DISCUSSION
==========

Operators are caught up with a dilemma when postoperative native AVF's thrill is absent or unsatisfactory, because presence of on table thrill and bruit are indicators of successful AVF creation. In other words, absence of on table thrill predicts early failure of AVF \[[@b7-vsi-31-20]\], and revision or intervention is not easy in failed native AVFs. For this reason, in every patient with newly-created AVFs with no thrill, our protocol was to perform fistulograms and immediate intervention (reason why we have no control group in our center).

In most of our cases, anatomical lesions rather than anastomosis technique itself was the main problem, such as the presence of very short stenotic venous or arterial lesions, non-distensible veins, kinked outflow with surrounding soft tissue and vasospasm. Unexpected venous stenosis was the main cause of flow-limitation in newly created AVFs ([Fig. 2](#f2-vsi-31-20){ref-type="fig"}). Sometimes, combined lesions (artery and vein) were found ([Fig. 3](#f3-vsi-31-20){ref-type="fig"}). There was a single case of arterial spasm ([Fig. 4](#f4-vsi-31-20){ref-type="fig"}). The flow-limiting lesion was resolved except in 1 case of wiring failure, with a satisfactory technical success rate of 95.8%. Moreover, once AVF flow was restored, all the accesses grew up as a functional hemodialysis access, even though about one third of them needed a secondary balloon angioplasty.

Short vein lesions can be skipped in preoperative duplex scan \[[@b8-vsi-31-20],[@b9-vsi-31-20]\]. Moreover, postoperative flow-limiting lesions may be hidden preoperatively, because it is difficult to evaluate the distensibility and elasticity of vessels with duplex scan \[[@b10-vsi-31-20],[@b11-vsi-31-20]\]. Focal vessel wall scars and mural thrombi may be present from previous vessel injury such as prolonged indwelling catheterization and frequent venous blood sampling. Focal stiff vessel lesions may lead to postoperative AVF flow limitation, because after AVF creation, the lesion does not distend as the other segments.

A major concern of IPBA is the stability of the anastomosis site and the possibility of anastomosis rupture. However, in our experience, there was no case of rupture. There was only one case of operation site hematoma but was not related with the anastomosis. In our experience, IPBA is an effective and safe procedure.

There are several reports about intraoperative intervention during native AVF creation. The intervention includes balloon pre-dilatation of small sized veins \[[@b12-vsi-31-20]\] or dilatation of vein with vessel probes \[[@b3-vsi-31-20]\]. However, to our knowledge, there is no report that shows the salvage effect of IPBA for newly created AVF with threatened flow (AVF with no thrill).

From our experience, IPBA can be summarized as follows: First, IPBA can be used as a salvage procedure in newly-created, flow-limiting AVFs. Second, with this salvage procedure, the success rate of native AVF creation can be improved. Third, IPBA has an educational effect in that the operators can look back their technique with immediate postoperative angiography. Fourth, IPBA can be used in challenging cases with short vessel lesions. If the operator keeps IPBA in mind and gets used to it, the ideal native wrist AVF can be created rather than upper arm AVF or artificial graft, even in the presence of focal vein stenosis or thrombus. These are the reasons why we have adopted this practice in our institute.

CONCLUSION
==========

IPBA is a useful, effective and safe procedure for salvage of newly-placed, flow-limiting native AVF in our experience.

This article was presented at the congress of Asian Society for Vascular Surgery 2014.

![Primary patency rate after immediate postoperative balloon angioplasty. AVF, arteriovenous fistula.](vsi-31-20f1){#f1-vsi-31-20}

![(A) Immediate postoperative balloon angioplasty; focal vein stenosis. (B) Conventional 4 mm-sized balloon was used. (C) Post-ballooning angiography showed resolved venous stenosis. Arteriovenous access was maturated after 4 weeks.](vsi-31-20f2){#f2-vsi-31-20}

![(A) Immediate postoperative balloon angioplasty; combined artery and vein lesions. (B) Conventional 3 mm-sized balloon was used for the arterial stenosis and (C) 4 mm balloon for the venous lesion. (D) Post-ballooning angiography showed resolved stenosis. (D) Arterio venous fistula (AVF) flow was restored and arteriovenous access was maturated after 6 weeks.](vsi-31-20f3){#f3-vsi-31-20}

![(A) Immediate postoperative balloon angioplasty; radial artery spasm (arrow). (B) Arterial spasm was not relieved after waiting for a few minutes, thus the spastic radial artery was ballooned (3 mm) to improve radial artery inflow. Arteriovenous fistula flow was restored and arteriovenous access was maturated after 3 weeks.](vsi-31-20f4){#f4-vsi-31-20}

###### 

Patient characteristics (total number of patient=24)

  Characteristic         Value
  ---------------------- -----------
  Age (y)                62.0±12.7
  Gender (male:female)   15:9
  Location of access     
    Wrist                16 (66.7)
    Forearm              4 (16.7)
    Elbow                4 (16.7)
  Anastomosis type       
    Radiocephalic        20 (83.3)
    Brachiocephalic      4 (16.7)

Values are presented as mean±standard deviation or number (%).

###### 

Vessel characteristics (total number of patient=24)

  Characteristic                                                                Value
  ----------------------------------------------------------------------------- -----------
  Vein diameter (mm)[^a^](#tfn3-vsi-31-20){ref-type="table-fn"}                 
    ≥2.5                                                                        9 (37.6)
    1.5--2.5                                                                    11 (45.8)
    \<1.5                                                                       4 (16.7)
  Artery diameter (mm)[^a^](#tfn3-vsi-31-20){ref-type="table-fn"}               
    ≥2.5                                                                        9 (37.6)
    1.5--2.5                                                                    14 (58.3)
    \<1.5                                                                       1 (4.2)
  Location of flow-limiting lesion[^b^](#tfn4-vsi-31-20){ref-type="table-fn"}   
    Vein, only                                                                  19 (79.2)
    Artery, only                                                                3 (12.5)
  Combined (artery and vein)                                                    2 (8.3)
  Type of flow-limiting lesion[^b^](#tfn4-vsi-31-20){ref-type="table-fn"}       
    Stenosis                                                                    19 (79.2)
    Thrombosis                                                                  4 (16.7)
    Vessel spasm                                                                1 (4.2)

Values are presented as number (%).

Preoperative ultrasonographic finding,

postoperative angiographic finding.

###### 

Details of procedure

  Technical aspect                                                                         Value
  ---------------------------------------------------------------------------------------- --------------
  Approach (access)                                                                        24
    Radial artery                                                                          23 (95.8)
    Brachial artery                                                                        1 (4.2)
    Retrograde (cephalic vein)                                                             0
  Diameter of used sheath (in all cases, Fr)                                               5
  Size of used balloon (mm)                                                                
    3                                                                                      3 (12.5)
    4                                                                                      16 (66.7)
    5                                                                                      5 (20.8)
  Technical success rate[^a^](#tfn6-vsi-31-20){ref-type="table-fn"}                        23/24 (95.8)
  Secondary balloon angioplasty (patient no.)[^b^](#tfn7-vsi-31-20){ref-type="table-fn"}   7/23 (30.4)
  Maturation time (wk)                                                                     4.5±1.5
  Clinical success rate[^c^](#tfn8-vsi-31-20){ref-type="table-fn"}                         23/24 (95.8)

Values are presented as patient number (%) or mean±standard deviation.

Rate of successful arteriovenous fistula flow restoration after immediate postoperative balloon angioplasty,

balloonangioplasty for enhancing maturation,

rate of successful growth as a functional arteriovenous access.
